- Recent Funding
- Investors
- Guangxin Fund
Guangxin Fund portfolio
Guangxin Fund has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is PAM2L Biotechnologies's $29.97M Series A round in October 2026, which it led, alongside Business Opportunities for L'Oréal Development. That company is in Health and bio.
What Guangxin Fund invests in
- Health and bio · 1 · 100%
How Guangxin Fund invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $29.97M |
Guangxin Fund portfolio companies
PPAM2L Biotechnologies$29.97MSeries A · Oct 2026
| Company | Round with Guangxin Fund | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $29.97M · lead | $29.97M | Oct 22, 2026 Series A |
Most frequent co-investors
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Guangxin Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Guangxin Fund, which is a subset of its real portfolio. API: /api/v1/investors/guangxin-fund (get a free API key). More: the most active VC firms and new venture capital funds.